2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Caroline Farrington, PhD, discusses the importance of patient advocacy in colorectal cancer.
Caroline Farrington, PhD, postdoctoral fellow, Narla lab, University of Michigan, discusses the importance of patient advocacy in colorectal cancer (CRC).
Being diagnosed with CRC can be overwhelming for patients, says Farrington. Moreover, patients may be hesitant to ask questions about their care.
As such, it is necessary to empower patients to become more engaged in their treatment, explains Farrington. Additionally, patients should be reassured that they have input in the treatment selection process and, therefore, they should be well informed of their options.
Finally, a strong support system can allow patients to feel more comfortable during the time of diagnosis. As such, institutions should have measures in place to accommodate patients who lack a support system, Farrington concludes.
Related Content: